4//SEC Filing
McIntosh David M 4
Accession 0001140361-08-020325
CIK 0001228627other
Filed
Aug 26, 8:00 PM ET
Accepted
Aug 27, 4:45 PM ET
Size
11.0 KB
Accession
0001140361-08-020325
Insider Transaction Report
Form 4
McIntosh David M
Director
Transactions
- Award
Stock Options (right to buy)
2008-06-30+20,000→ 20,000 totalExercise: $3.24Exp: 2018-06-30→ Common Stock (20,000 underlying)
Holdings
- 20,000
Stock Options (right to buy)
Exercise: $0.80Exp: 2014-04-20→ Common Stock (125,000 underlying)
Footnotes (2)
- [F1]30% of the options vested and became exercisable on April 20, 2005; another 30% of the options vested and became exercisable on April 20, 2006; and the remaining 40% of the options vested and became exercisable on April 20, 2007.
- [F2]These options vest and become exercisable in full on June 30, 2009.
Documents
Issuer
REXAHN PHARMACEUTICALS, INC.
CIK 0001228627
Entity typeother
Related Parties
1- filerCIK 0001317248
Filing Metadata
- Form type
- 4
- Filed
- Aug 26, 8:00 PM ET
- Accepted
- Aug 27, 4:45 PM ET
- Size
- 11.0 KB